dijous, 22 de febrer del 2018

Novocure misses Q4 EPS by a penny, tops sales estimates

NovocureShares in Novocure (NSDQ:NVCR) rose slightly today in premarket activity after the medical device maker met sales expectations, but missed earnings estimates on Wall Street with its fourth quarter and full-year financial results.

The St. Helier, N.J.-based company reeled in losses this quarter, posting -$10.9 million on sales of $53.7 million for the 3 months ended Dec. 31, for sales growth of 78% compared with the same period last year.

Get the full story at our sister site, Drug Delivery Business News.

The post Novocure misses Q4 EPS by a penny, tops sales estimates appeared first on MassDevice.



from MassDevice http://ift.tt/2sSV3B1

Cap comentari:

Publica un comentari a l'entrada